In the published article, there was an error in affiliation of Dr. Tianhao Zhou. Instead of “1 Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, China; 5 Department of Breast Surgery, Affiliated Hospital of Jining Medical University, Jining, China; 6 Key Laboratory of Breast Cancer Prevention and Treatment of the Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, China; 7 Department of Medical Oncology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China”, it should be “6 Department of Medical Oncology, Shanghai First People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
DYNLT1, breast cancer, biomarker, prognosis, immune checkpoint blocking therapy
Citation
Miao S, Ju G, Jiang C, Xue B, Zhao L, Zhang R, Diao H, Yu X, Zhang L, Pan X, Zhang H, Zang L, Wang L and Zhou T (2024) Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer. Front. Med. 11:1375203. doi: 10.3389/fmed.2024.1375203
Received
23 January 2024
Accepted
25 January 2024
Published
05 February 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
11 - 2024
Updates
Copyright
© 2024 Miao, Ju, Jiang, Xue, Zhao, Zhang, Diao, Yu, Zhang, Pan, Zhang, Zang, Wang and Zhou.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tianhao Zhou wwwzhou0809@163.comLei Wang Wang198111lei@126.comLijuan Zang Lou19941205@163.com
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.